The δA isoform of calmodulin kinase II mediates pathological cardiac hypertrophy by interfering with the HDAC4-MEF2 signaling pathway

相似書籍

• Protein Kinase D3 Is a Pivotal Activator of Pathological Cardiac Hypertrophy by Selectively Increasing the Expression of Hypertrophic Transcription Factors
  由: Li, Changlin, et al.
  出版: (2011)
• Mef2 is Regulated by CaMKIIδ2 and a HDAC4/HDAC5 Heterodimer in Vascular Smooth Muscle Cells
  由: Ginnan, Roman, et al.
  出版: (2012)
• The δ isoform of CaM kinase II is required for pathological cardiac hypertrophy and remodeling after pressure overload
  由: Backs, Johannes, et al.
  出版: (2009)
• Reversal of pathological cardiac hypertrophy via the MEF2-coregulator interface
  由: Wei, Jianqin, et al.
  出版: (2017)
• Nuclear Translocation of Calmodulin in Pathological Cardiac Hypertrophy Originates from Ryanodine Receptor bound Calmodulin
  由: Oda, Tetsuro, et al.
  出版: (2018)